LINEAGE CELL THERAPEUTICS IN (LCTX) Institutional Shareholders

LINEAGE CELL THERAPEUTICS IN (LCTX) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026. The institutional investors covered on this page collectively reported approximately $152.51M in LCTX holdings during the latest filing period.

Broadwood Capital Inc is currently the largest disclosed institutional shareholder of LCTX tracked by InsiderSet, reporting ownership valued at approximately $64.92M in its June 30, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $51.54M, representing an estimated loss of -20.61% since the filing period.

The top 10 institutional shareholders tracked on this page collectively account for approximately 86% of the total disclosed LCTX value among the investors covered in this analysis. Major shareholders include Broadwood Capital Inc, Blackrock, Inc., Vanguard Capital Management Llc, and several other long-term asset managers with concentrated positions in LINEAGE CELL THERAPEUTICS IN (LCTX).

This page ranks the largest institutional LCTX shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.

Institutional Holders

127

Total Reported Value

$152.51M

Largest Holder

Broadwood Capital Inc

Largest Position

$64.92M

Insider Transactions (90d)

0

Latest Filing Quarter

Q2 2026

New Institutional Positions

173

Funds Exiting Positions

0

NameInvestor/ManagerPortfolio %QuantityReported BalanceCurrent Estimated ValueGain/loss Since FilingEstimated Portfolio Performance
Broadwood Capital Inc3.39%49,560,992$64,924,900$51,543,432-$13,381,468-20.61%
Blackrock, Inc.0.00%13,186,895$17,274,832$13,714,371-$3,560,461-20.61%
Vanguard Capital Management Llc0.00%9,054,918$11,861,943$9,417,115-$2,444,828-20.61%
Defender Capital, Llc.2.81%6,598,899$8,644,558$6,862,855-$1,781,703-20.61%
Geode Capital Management, Llc0.00%5,299,457$6,944,050$5,511,435-$1,432,615-20.63%
Raffles Associates Lp5.80%5,197,788$6,809,102$5,405,700-$1,403,402-20.61%
Fifth Third Bancorp0.01%4,600,000$6,026,000$4,784,000-$1,242,000-20.61%
Millennium Management Llc0.00%3,018,567$3,954,323$3,139,310-$815,013-20.61%
State Street Corp0.00%2,314,180$3,031,576$2,406,747-$624,829-20.61%
Vanguard Fiduciary Trust Co0.00%1,668,629$2,185,904$1,735,374-$450,530-20.61%
Northern Trust Corp0.00%1,656,651$2,170,213$1,722,917-$447,296-20.61%
Morgan Stanley0.00%1,471,462$1,927,615$1,530,320-$397,295-20.61%
Renaissance Technologies LLCJim Simons0.00%1,344,829$1,761,726$1,398,622-$363,104-20.61%
Marshall Wace, Llp0.00%1,282,347$1,679,875$1,333,641-$346,234-20.61%
Vanguard Portfolio Management Llc0.00%1,273,311$1,668,037$1,324,243-$343,794-20.61%
Ubs Group Ag0.00%687,051$900,036$714,533-$185,503-20.61%
Red Crane Wealth Management, Llc0.58%597,263$782,415$621,154-$161,261-20.61%
Charles Schwab Investment Management Inc0.00%577,435$756,440$600,532-$155,908-20.61%
Barclays Plc0.00%508,668$666,354$529,015-$137,339-20.61%
Squarepoint Ops Llc0.00%444,774$582,654$462,565-$120,089-20.61%
Goldman Sachs Group Inc0.00%433,266$567,578$450,597-$116,981-20.61%
Citadel Advisors Llc0.00%426,169$558,282$443,216-$115,066-20.61%
Bank Of America Corp0.00%424,373$555,928$441,348-$114,580-20.61%
Bank Of New York Mellon Corp0.00%391,675$513,094$407,342-$105,752-20.61%
Flputnam Investment Management Co0.00%304,562$398,976$316,744-$82,232-20.61%
Nuveen, Llc0.00%245,384$321,453$255,199-$66,254-20.61%
Bridgeway Capital Management, Llc0.01%221,000$289,510$229,840-$59,670-20.61%
Mcmillan Office, Inc.0.03%216,000$282,960$224,640-$58,320-20.61%
Fmr Llc0.00%192,926$252,733$200,643-$52,090-20.61%
Deutsche Bank Ag\0.00%183,324$240,154$190,657-$49,497-20.61%
Wells Fargo & Company/Mn0.00%183,117$239,884$190,442-$49,442-20.61%
Price T Rowe Associates Inc0.00%151,233$199,000$157,282-$41,718-20.96%
Raymond James Financial Inc0.00%148,292$194,263$154,224-$40,039-20.61%
Rhumbline Advisers0.00%129,536$169,684$134,717-$34,967-20.61%
Metlife Investment Management, Llc0.00%110,301$144,494$114,713-$29,781-20.61%
Commonwealth Equity Services, Llc0.00%102,178$133,850$106,265-$27,585-20.61%
Williams Jones Wealth Management, Llc.0.00%101,300$132,703$105,352-$27,351-20.61%
Invesco Ltd.0.00%100,129$131,169$104,134-$27,035-20.61%
Jpmorgan Chase & Co0.00%86,526$116,810$89,987-$26,823-22.96%
Citigroup Inc0.00%86,603$113,450$90,067-$23,383-20.61%
Vanguard Global Advisers, Llc0.00%85,795$112,391$89,227-$23,164-20.61%
Mirae Asset Global Etfs Holdings Ltd.0.00%84,857$111,163$88,251-$22,912-20.61%
Trust Co Of Toledo Na0.01%83,795$109,771$87,147-$22,624-20.61%
Wealthspire Advisors, Llc0.00%80,088$104,916$83,292-$21,624-20.61%
Susquehanna International Group, Llp0.00%62,427$81,779$64,924-$16,855-20.61%
Xtx Topco Ltd0.00%58,365$76,458$60,700-$15,758-20.61%
Two Sigma Investments, Lp0.00%54,947$71,981$57,145-$14,836-20.61%
Police & Firemen'S Retirement System Of New Jersey0.00%54,351$71,200$56,525-$14,675-20.61%
Jane Street Group, Llc0.00%49,783$65,216$51,774-$13,442-20.61%
Cibc World Market Inc.0.00%47,050$61,636$48,932-$12,704-20.61%
Showing 50 of 127

Frequently asked questions about LCTX

  • Who owns the most LCTX stock?

    The largest holders of LCTX are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for LINEAGE CELL THERAPEUTICS IN (LCTX).

  • Is LCTX widely held by superinvestors?

    Many widely followed stocks like LCTX appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly LCTX is represented among the institutional managers we track.

  • What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?

    Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.